The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2014Rating Segmental Progression of Cardinal Motor Symptoms in Early Parkinson's Disease
Objective/Rationale:
We recently reported a new, practical approach to rate segmental progression of cardinal motor symptoms in Parkinson's disease (PD) at early stages. We computed four new scores —... -
Access to Data and Biospecimens, 2014Contribution of the Unfolded Protein Response to Idiopathic and LRRK2-driven Parkinson’s Disease
Objective/Rationale:
The unfolded protein response (UPR) is a life-death switch that instructs aged and overworked cells to self-destruct. We hypothesize that hyper-activation of the UPR... -
Research Grant, 2014Role of LRRK2 in Alpha-synuclein-induced Neurodegeneration: Supplement
Promising Outcomes of Original Grant:
We seek to develop a robust and standardized pre-clinical model relevant to late-onset Parkinson’s disease (PD) that will identify clinically viable LRRK2 kinase... -
Rapid Response Innovation Awards, 2014Integrative Genomic Approach to Discover Disease Mechanisms Underlying Parkinson’s Disease
Objective/Rationale:
Complex diseases such as Parkinson’s are caused by a combination of genetic, environmental and lifestyle factors that all lead to different causal regulation... -
Research Grant, 2014Tumorigenesis in Parkinson’s Disease
Objective/Rationale:
The aim of the study is to investigate whether disease-causing genetic mutations in Parkinson’s disease (PD), particularly in the LRRK2 gene, also predispose... -
Target Validation, 2014Targeted Disruption of TRIM28 to Reduce Alpha-synuclein Levels
Objective/Rationale:
We have previously performed a screen to find new pathways that may regulate alpha-synuclein, the toxic protein that accumulates in the cells of people with Parkinson’s disease (PD...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.